You can buy or sell EGRX and other stocks, options, ETFs, and crypto commission-free!
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. Read More The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Woodcliff Lake, New Jersey
52 Week High
52 Week Low
Yahoo FinanceMay 15
Eagle Pharmaceuticals, Inc. to Present at 2019 RBC Capital Markets Global Healthcare Conference
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (EGRX) announced today that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 2019 RBC Capital Markets Global Healthcare Conference as follows: Date: Wednesday, May 22, 2019 Time: 10:00 a.m. Eastern Daylight Time Location: InterContinental New York Barclay, NYC Webcast: http://www.veracast.com/webcasts/rbc/healthcare2019/96314260749.cfm Scroll to continue with...
Yahoo FinanceMay 9
Hedge Funds Have Never Been More Bullish On Eagle Pharmaceuticals Inc
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking. Hedge funds underperform because their net exposure in only 40-70% and they charge exorbitant fees. No one knows what the future holds and how market participants will react to the bountiful news that floods in each day. However, hedge funds' consensus picks on average deliver market beating returns. For example in the first 2.5 months of this year the Standard and Poor’s 500 Index returned appr...
Stock Highlights: Eagle Pharmaceuticals (NASDAQ: EGRX)
Eagle Pharmaceuticals is in the drug manufacturers industry and is in the healthcare sector. The company CEO is Scott L. Tarriff. Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Previous Intraday Trading Performance: The EGRX stock showed a previous change of 2.63% with an open at 57.07 and a close of 58.45. It reached an intraday high of 59.58 and a low of 55.40. See...
$0.84 per share
$1.01 per share